HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $38 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on Adicet Bio (NASDAQ:ACET) and maintains a $38 price target.

June 27, 2023 | 10:07 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on Adicet Bio (NASDAQ:ACET) and maintains a $38 price target.
The reiterated Buy rating and maintained price target by HC Wainwright & Co. analyst Edward White indicates a positive outlook for Adicet Bio's stock in the short term. This news is likely to be perceived positively by investors and could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100